Most Variation in All-Cause Mortality Explained by Mass COVID-19 Vaccination
Australian Ecological Analysis Points to Vaccine Campaign Causing Rising Death Counts
By Peter A. McCullough, MD, MPH | Courageous Discourse | September 1, 2024
After a pandemic, all cause mortality should go down due to a culling effect of the frail and vulnerable. We saw acute COVID-19 become the proximate cause of death in many seniors who were in the final year of natural life.
Now an analysis from Allen indicates that all-cause mortality is up in heavily vaccinated Australia and that at least two thirds in the variation per region is explained by mass COVID-19 vaccination. There are numerous well-documented fatal vaccine serious adverse events which are piling up months and years after the shots. Cumulative toxicity is another factor as a single person is not vaccinated just with the primary series (first two injections), but continued dosing every six months.

Allen, DE. 2024. The correlation between Australian Excess Deaths by State and Booster Vaccinations. Medical Research Archives, [online] 12(7).https://doi.org/10.18103/mra.v1 2i7.5485
These data call for a direct data merge of the vaccine administration and death data in Australia to explore these very uncomfortable relationships. Because the Australian government pushed the vaccines so hard, officials have been stonewalling the public on this important next analysis.
Japan’s Largest MSM Broadcaster, NHK, Releases Groundbreaking Feature on mRNA Vaccine Harms
PharmaFiles by Aussie17 | August 30, 2024
Japanese citizens were shocked on the morning of August 28 as their largest national broadcaster, NHK, decided to air a special feature on the COVID-19 vaccine relief system. This program highlighted real-life experiences of individuals who have suffered severe side effects, prompting an overwhelming public response with over 2000 messages received.
In a surprising turn of events, NHK’s popular Morning Show, Asaichi, has taken a bold step. Once dismissive of doubts about vaccine safety, the show recently focused on the challenges and realities faced by those affected by mRNA experimental vaccine side effects. This change in stance marks a pivotal U-Turn in the ongoing national conversation about the experimental mRNA’s safety and transparency.
The program’s new focus was echoed in the unexpected surge of viewer engagement. “We have received more than 2000 messages from viewers today. Thank you very much,” the host announced, signaling widespread public interest and concern.
One chilling account came from a viewer who detailed their struggle after the third vaccine dose: “My headaches became severe. Although they have lessened since the beginning, the symptoms have persisted for more than two years. It has been two and a half years of vaccine aftereffects.” Frustration with the bureaucratic hurdles in seeking relief was evident: “It’s difficult to go collect documents because of my leg pain, so I urgently wish the process to be simplified as soon as possible.”
Another viewer recounted a deeply personal tragedy: “Right after vaccination, my mother developed a serious illness and passed away.” Their story was not just about personal loss, but also about the social repercussions of questioning vaccine side effects. “During the period when I was collecting application documents after my mother’s illness and passing, I’ve been met repeatedly with heartless comments just for questioning the connection with the vaccine.”
The show also featured Misu from Ibaraki Prefecture, a former healthcare worker in her 40s, who shared her ongoing battle. Since receiving her third dose, she has struggled with “pain and numbness in the vaccinated arm, fatigue, and other symptoms.” Misu’s plea was simple yet profound: “I hope the government and media report this properly. Voices are being raised to spread awareness about the suffering caused by side effects.”
This feature on NHK’s Asaichi has not only brought attention to individual struggles but has also highlighted a broader societal issue: the difficulty in openly discussing vaccine side effects without backlash. It presents a call to action for society to foster an environment where sharing such experiences does not invite judgment but rather understanding and empathy.
Two days following the national broadcast, Japan’s Health Minister, Keizō Takemi, made an unexpected statement: “Regarding whether health damage from the COVID-19 vaccine constitutes drug-induced injury, our response at this point is that we would like to refrain from commenting.”
It looks like they are no longer saying that it is 100% safe and effective!
$3,000 and a Toy: Novavax Dangles Incentives to Fill Clinical Trials on COVID Shots for Babies, Kids
By Brenda Baletti, Ph.D. | The Defender | August 29, 2024
Novavax is offering parents up to $3,000 to enroll their children in the vaccine maker’s Phase 2/3 COVID-19 vaccine trial for infants and children ages 6 months to 11 years. The offer also includes a stuffed animal for each child.
The “Hummingbird” trial is testing two primary shots and a booster shot of Novavax’s adjuvanted recombinant spike protein nanoparticle vaccine in children. The study, which began in 2022, is enrolling 3,600 children.
The study, which began in the U.S., is expected to run through 2025 and will be conducted in the U.S. and other countries.
The children will receive three injections and visit the clinic eight times. Parents will participate in three phone calls and keep an e-diary of the vaccine’s effects on their child. Some children will receive two additional injections, for a total of five shots.
The study website promises, “You will be compensated for your time and travel regardless of your immigration status. Transportation to the study site may also be provided, as available. No health insurance is required to participate.”
Recruitment materials from Be Well Clinical Studies, which is running one of the U.S. trials, state that compensation can be more than $3,000 over two years.
A 2023 video explaining the study also promises incentives for the children, including “a Covid stuffed animal.”
In the video, a pastor from Louisiana who has four children enrolled in the study said incentives like the stuffed animal made the kids even “more excited than the parents” to participate.
The video features Dr. Jibran Atwi who is running a Hummingbird trial in Lafayette, Louisiana. He encouraged people to participate in the study, because COVID-19 severely affected kids, particularly through lockdowns and lost schooling.
Atwi also said that COVID-19 can be “very disruptive” because if a child has to stay home from school, parents may not be able to go work and the child may have to be isolated from their grandparents.
“Prevention,” he said, “is the best medicine.” He added that there had been an “impressive response” from parents who wanted to participate.
Research shows that young children rarely get sick from COVID-19 and that the illness is typically mild in older kids.
Atwi received over $2 million in research funding in 2023 from Big Pharma, according to the Open Payments website.
Most of that funding came from Genzyme — a Sanofi subsidiary — and from Sanofi, which shares the co-exclusive licensing agreement with Novavax to commercialize its COVID-19 vaccine.
In 2022, Atwi received over $1 million, largely from AstraZeneca and Genzyme.
Last week, the U.S. Food and Drug Administration (FDA) granted emergency use authorization to Pfizer and Moderna’s 2024-2025 mRNA COVID-19 shots, but Novavax’s 2024-2025 formula has not yet been authorized.
The FDA has authorized previous versions of the Novavax vaccine, but only for children ages 12 and up.
High payments place children ‘at risk of coercion’
Other pharmaceutical companies that have paid research subjects large sums of money have come under scrutiny. In the United Kingdom (U.K.), Moderna was criticized for initially offering children’s families 1,505 pounds ($1,984 dollars) to participate in its NextCOVE clinical trial, which is testing Moderna’s mRNA vaccine in children ages 12 and up.
The Children’s Covid Vaccine Advisory Council submitted a complaint to the U.K.’s Prescription Medicines Code of Practice Authority (PMCPA) — an industry trade group that regulates ethical practices — raising concerns about “inappropriate financial inducement” offered to children and their parents to participate in the trial.
The council cited concerns raised by the research ethics committee (REC) that approved the clinical study. Regarding the 1,500-pound payment they wrote:
“This amount seems much higher than what would be considered a reasonable reimbursement and therefore would contravene clinical trial regulations. The Medicines for Human Use (Clinical Trials) Regulations (2004) explicitly prohibit the giving of incentives or financial inducements to children… or their parents.”
The REC said the amount, “placed the children at risk of coercion,” and the organization required that Moderna reduce the offer before recruitment could begin. Moderna reduced the amount to 185 pounds ($244 dollars).
Yet, according to the complaint, at least one pediatrician continued to offer the high enrollment compensation.
The PMCPA sanctioned Moderna, and the case report on the issue is currently pending.
If the PMCPA determines a pharmaceutical company has breached the industry code, it can require the company to pay administrative charges or issue a corrective statement. Or, it may request a compulsory audit of the company.
In the U.S., Be Well is also advertising that it will pay parents $2,400 for enrolling their infants and toddlers, ages 5-23 months, in Moderna’s Rhyme Trial for an mRNA RSV and a human metapneumovirus (hMPV) vaccine.
According to the clinicaltrials.gov website, Be Well withdrew from the Moderna RSV study, but the website is still advertising to recruit participants.
Be Well is run by founder and director Dr. Mark Carlson, a geriatrician, who has taken nearly $3 million in research funding from Big Pharma, mostly from Moderna, since 2021.
Moderna did not respond to The Defender’s inquiry about compensation offered to children’s families to participate in these studies.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
Biden-Harris Administration Defends Big Tech Censorship Pressure Following Zuckerberg’s Admission

By Didi Rankovic | Reclaim The Net | August 28, 2024
The Biden-Harris White House looks determined to justify and normalize the practice of the government colluding with private companies, in this instance Big Tech, to censor speech.
After Meta CEO Mark Zuckerberg on Monday sent a letter to the House Judiciary Committee, admitting that his company came under pressure from the current administration to conduct censorship and that he “believes” that was wrong – the White House doubled down on the controversial, and quite possibly, unconstitutional, policy.
In his letter, Zuckerberg chose to focus on Meta censoring content related to COVID-19, and in response, a White House spokesman revealed the government does not share Zuckerberg’s stance that the policy of pressure was wrong.
“Encouragement” is how that’s phrased. “When confronted with a deadly pandemic, this administration encouraged responsible actions to protect public health and safety,” stated the White House spokesman to media requests.
He further justified the actions described by Zuckerberg as needed because the White House believes private companies, including those from the tech industry, “should take into account the effects their actions have on the American people.”
And with the stage set in this way – the spokesman concluded that these companies are then free to make “independent choices about the information they present.”
But Zuckerberg’s letter to the Judiciary Committee Chairman Jim Jordan does a pretty good job of explaining how these “independent choices” get made. Senior figures from the Biden administration, Zuckerberg stated, in 2021 “repeatedly pressured our (Facebook, Instagram) teams for months to censor certain COVID-19 content, including humor and satire.”
The decision on content removal, and introduction of new rules into platform policies to facilitate censorship, Zuckerberg concedes, was “ultimately ours” – but made under pressure.
If Meta tried to defy these “suggestions” – the administration showed “a lot of frustration.”
“I believe the government pressure was wrong, and I regret that we were not more outspoken about it,” the letter, sent in response to the Committee’s subpoena first issued in early 2023, reads.
The Committee has been investigating how the government may have colluded with private companies to suppress speech it disapproves of, and whether those actions constitute First Amendment violations.
Even before the current Biden-Harris administration came to power, Facebook was being steered in a desired direction, one example being the notorious case of the censorship of the Hunter Biden laptop news story, the Zuckerberg letter reveals.
The FBI contacted the social media giant with a “warning” that there could be an anti-Biden family “Russian disinformation” campaign – and Facebook heeded it by “fact-checking and temporarily demoting (links to the article).”
AstraZeneca promised to pay medical expenses for anyone injured during its COVID vaccine trials. Now it wants immunity
By Michael Nevradakis, Ph.D. | The Defender | August 22, 2024
AstraZeneca claims it is not obligated to pay medical expenses for a woman injured by its COVID-19 vaccine during a clinical trial because the company is immune from liability under the Public Readiness and Emergency Preparedness Act (PREP Act).
The British-Swedish vaccine maker is asking the court to dismiss a lawsuit filed by Brianne Dressen, who alleges the company reneged on its contract which promised to compensate clinical trial participants for injuries they sustained.
Dressen, founder of React19, a nonprofit advocating for vaccine injury victims, filed a breach of contract lawsuit against AstraZeneca in federal court in May.
According to the lawsuit, AstraZeneca’s consent form for trial participants stated, “If you become ill or are injured while you are in this research study, you must tell your study doctor straight away. The study doctor will provide medical treatment or refer you for treatment.”
Dressen alleged she suffered injuries and disability as a direct result of her November 2020 vaccination, resulting in prohibitive medical costs — with one medication alone costing $432,000 a year. AstraZeneca offered her only $1,243.30 in compensation, prompting her to file the breach of contract claim.
In its motion to dismiss, AstraZeneca claimed it is fully immune from Dressen’s breach of contract claim under the PREP Act of 2005, which provides a liability shield to COVID-19 vaccine manufacturers.
“This action is barred by the PREP Act, which renders AstraZeneca ‘immune from suit and liability under Federal and State law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a covered countermeasure,” the motion states.
According to AstraZeneca’s motion, the company did not waive its PREP Act immunity, but if it did, “any waiver would be strictly confined to ‘the costs of medical treatment for research injuries, provided that the costs are reasonable, and you did not cause the injury yourself.’”
AstraZeneca said Dressen’s claim that the company’s COVID-19 vaccine caused her neurological injuries falls outside the scope of such “research injuries.”
“This is a product liability case alleging personal injuries from the administration of AstraZeneca’s COVID-19 vaccine,” AstraZeneca said, seemingly distinguishing between “research injuries” and “personal injuries.”
AstraZeneca also said Dressen’s lawsuit should not be considered a breach-of-contract claim, but a product liability claim — which would preclude Dressen’s claim “under the Utah Product Liability Act’s two-year statute of limitations.”
Dressen’s opposition to AstraZeneca’s motion to dismiss disputed the product liability claim, stating, “AstraZeneca asks this Court to do what no court has ever done: grant ‘complete immunity’ for contractual violations so long as the violations relate to the administration of covered countermeasures under the PREP Act.”
The document cites precedent exempting breach-of-contract claims from the PREP Act’s immunity provisions. “Each court that has addressed claims of immunity for state contract claims has rightfully held that the PREP Act does not apply.”
Dressen also argued that AstraZeneca waived its immunity “by clearly and unmistakably promising to pay the cost of research injuries.”
In a reply brief filed last week, AstraZeneca repeated its original claims. “Plaintiff’s claims fall squarely within the scope of AstraZeneca’s PREP Act immunity and should be dismissed.”
A hearing on AstraZeneca’s motion to dismiss is scheduled for Oct. 29.
‘PREP Act wasn’t intended to excuse such fraudulent and illicit behavior’
The U.S. never granted emergency use authorization for the AstraZeneca COVID-19 vaccine, citing safety concerns.
In its motion to dismiss though, AstraZeneca claimed, “With the protections of the PREP Act in place, AstraZeneca and its partners successfully developed a lifesaving vaccine in a matter of months, an unprecedented scientific achievement.”
Ray Flores, a health freedom rights attorney unconnected to the lawsuit, told The Defender that the PREP Act’s liability shield for “covered countermeasures” extends to products being tested during clinical trials — but not in cases where there has been a breach of contract.
“A breach of contract such as this should obviously be excluded since the PREP Act is essentially a product liability protection statute,” Flores said.
He added:
“I’d like to think the PREP Act wasn’t intended to excuse such fraudulent and illicit behavior. But so far, under the guise of a pandemic emergency, the courts have determined that anything goes.
“This is the first PREP challenge that alleges a viable breach of contract. Since AstraZeneca’s guarantee was in writing, it has an excellent chance of winning.”
According to Dressen, two days after Dressen signed the consent form, AstraZeneca amended the form to state that its vaccine may cause “neurological disorders” such as “demyelinating disease,” which could “cause substantial disability” or death “if not treated promptly.”
Within hours of getting her first dose, Dressen experienced tingling in her right arm — a neurological condition known as paresthesia — and blurred vision and vomiting.
In the ensuing weeks, her condition worsened, with the paresthesia spreading to her legs, resulting in disability and multiple diagnoses indicating her symptoms were related to her vaccination.
This included a diagnosis in 2021 by the National Institutes of Health (NIH) of post-vaccine neuropathy, which NIH neurologists said caused Dressen’s “dysautonomia” and “chronic inflammatory demyelinating polyneuropathy.”
Dressen, who was 39 when she was vaccinated, was previously a preschool teacher but is now unable to work.
In May, AstraZeneca announced the withdrawal of its COVID-19 vaccine globally — though the company said it based its decision on the “surplus of available updated vaccines,” resulting in reduced demand for its vaccine.
The vaccine generated over $5.8 billion in sales globally, with the help of the Bill & Melinda Gates Foundation, which funded and promoted the vaccine in other countries. Several countries later stopped administering the AstraZeneca vaccine due to safety concerns.
In an ongoing class-action lawsuit in the United Kingdom (U.K.) against AstraZeneca, plaintiffs allege that they were injured — or their family members died — after getting the shot.
In documents AstraZeneca submitted to the U.K. High Court earlier this year, the company admitted that its COVID-19 vaccine “can, in very rare cases, cause TTS” — vaccine-induced thrombosis with thrombocytopenia syndrome, which causes the body to produce life-threatening blood clots.
According to The Telegraph, the U.K.’s Vaccine Damage Payment Scheme has approved 175 applications claiming harm caused by the COVID-19 vaccines, at a set amount of 120,000 pounds (approximately $156,000) per claim, adding that “Around 97 per cent of claims awarded relate to the AstraZeneca jab.”
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
CDC USES ‘COVID SURGE’ TO STOKE FEAR
The HighWire with Del Bigtree | August 22, 2024
The CDC is using new, questionable techniques to declare a ‘COVID surge’ and stoke fears. Coincidentally, a new booster hits the market as students head back to school. Jefferey Jaxen reports.
Dr. Peter McCullough: COVID Shots for Kids ‘the Last Straw’
By Brenda Baletti, Ph.D. | The Defender | August 19, 2024
“A child today faces well over a hundred shots,” cardiologist Dr. Peter McCullough told host Mat Staver on a recent episode of “Freedom Alive.” Many of those shots are for infectious diseases of the past or contemporary illnesses that don’t pose a risk to infants.
McCullough said the “inflection point” was the 1986 National Childhood Vaccine Injury Act, which freed vaccine manufacturers from liability for vaccine injuries. “We saw essentially a vaccine bonanza develop,” he said, and “excessive, unnecessary” vaccination could be leading to serious side effects.
Those vaccines start just after a baby is born, he said, when they are given the hepatitis B vaccine.
As a cardiologist, dealing with blood and body fluids, McCullough said the vaccine is appropriate for him, but babies are not at risk for it unless their mother has the illness or is an active IV drug user. For most babies, he said, it is a “completely unnecessary shot on the first day of life.”
The Centers for Disease Control and Prevention (CDC) in October 2023 recommended newborns receive Beyfortus, the monoclonal antibody shot meant to protect babies from RSV-related illness.
“This has no safety track record,” he said. “We’ve never given a synthetic antibody to a baby ever in the history of medicine, and now it’s being given uniformly with no idea of what is going to happen to the baby’s immune system over the next several weeks or months.”
The clinical trials were inconclusive as to whether Beyfortus is safe, and evidence from France shows increased mortality among infants after the shot was introduced, he said.
McCullough said the broader safety concerns stem largely from the fact that so many are given in combination. “For some babies, it’s too much,” he said.
Excessive vaccination, he explained, sends the immune system into overdrive, which can lead a baby to develop a fever and a febrile seizure (convulsion).
Research shows febrile seizures have about a 40% chance of causing permanent neurologic injury, ranging from epilepsy to attention-deficit/hyperactivity disorder to autism spectrum disorder.
Staver said many parents who saw their children develop autism post-vaccination are told either that it isn’t true or it’s just a coincidence because there is no evidence of such a link.
“The direct observation by a mother and father of their child is the strongest evidence,” McCullough said, citing Dr. Andy Wakefield’s controversial 1998 study.
McCullough also cited a recent study by the Children’s Health Defense science team, which showed that combining multiple vaccines is dangerous. Spacing them out and giving them individually — rather than combining three vaccines into one shot, like the measles-mumps-rubella, or MMR, vaccine — is safer, he said.
And, he said, all children do not need all vaccines. Which vaccines a child gets should be determined on a risk basis. For example, a child with cystic fibrosis might need the respiratory illness vaccines, but healthy kids probably don’t.
Yet these vaccines are given to all children in part, he said, because the people who advise the CDC on which vaccines should be recommended for children have serious conflicts of interest — most take money from Big Pharma. Then schools enact mandates based on those recommendations, leaving parents feeling as if they have no choice.
Vaccine makers lobby state legislators to continually increase the list of mandatory vaccines.
McCullough said:
“Can you imagine if you had a product that treats an illness? You would have to treat a small number of people in a population. But if you have a vaccine, that means the whole entire population has to receive the product.
“A product that must be purchased by the entire population with no liability is an absolute boon to any purveyor of that product.”
McCullough said the CDC has turned a blind eye to vaccine safety. For example, none of the childhood vaccines have been studied for safety when given in combination.
He added that Dr. Paul Thomas reported in The Defender that pediatricians receive substantial incentives from insurance companies to vaccinate certain high percentages of their patients.
For lower-income kids, there is also government financial support to ensure that the vast majority of the population is vaccinated against legacy diseases like diphtheria, tetanus, polio and other diseases that are either no longer commonly circulating or for which good treatments exist.
For many, McCullough said, the recommendation that children take the COVID-19 vaccine, given its alarming safety data, was “the last straw.”
“That act was irresponsible. It triggered the World Council for Health, which is an evidence-based, consensus-driven body to recommend waiting on all the childhood vaccines,” he said.
Vaccines are not safe or effective enough to mandate, McCullough said. “Every parent and child unit should be able to make their own decisions free of any pressure, coercion, or threat of reprisal.”
Watch the interview here.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
COVID-19 Vaccines Cause far More Myocarditis than Infection, Overall Risks Greatly Outweigh Theoretical Benefits
BREAKING PUBLICATION
By Peter A. McCullough, MD, MPH | Courageous Discourse™ | August 19, 2024
When the Springer Nature CUREUS Journal of Biomedical Sciences retracted one of the most comprehensive and valid risk-benefit analyses of the COVID-19 vaccines, they probably had no idea the message would be greatly amplified and now fully published in a pair of papers in the International Journal of Vaccine Theory, Practice, and Research.
This manuscript evaluated all of the published data and has completely overturned a false narrative held by government agencies and the American College of Cardiology who erroneously assert that SARS-CoV-2 infection poses a greater risk of heart damage than vaccination. Mead et al importantly conclude the vaccines cause actual adjudicated and oftentimes fatal myocarditis while the infection remains a theoretical risk without adjudicated, autopsy proven cases.
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2. (2024). International Journal of Vaccine Theory, Practice, and Research , 3(2), 1246-1315. https://doi.org/10.56098/w66wjg87
The paper goes into great depth to enumerate harms from the shot along the lines of six domains where observed adverse events greatly outweigh claimed, theoretical benefits:
“We then categorize the principal adverse events associated with the modmRNA products with a brief systems-based synopsis of each of the six domains of potential harms: (1) cardiovascular, (2) neurological, (3) hematologic; (4) immunological, (5) oncological, and (6) reproductive. We conclude with a discussion of the primary public health and regulatory issues arising from this evidence-informed synthesis of the literature and reiterate the urgency of imposing a global moratorium on the modmRNA-LNP-based platform.”
The final call is clear, the COVID-19 mass, indiscriminate vaccination campaign should come to an end and with it, the four-year long false “safe and effective” narrative from the Bio-Pharmaceutical Complex.





